Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy

Published:2022-05-20 Issue:6 Volume:8 Page:692-704
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Huang Ziyin^ORCID,Callmann Cassandra E.^ORCID,Wang Shuya,Vasher Matthew K.^ORCID,Evangelopoulos Michael^ORCID,Petrosko Sarah Hurst,Mirkin Chad A.^ORCID

Funder

American Cancer Society

American Committee for the Weizmann Institute of Science

National Institutes of Health

Alexander S. Onassis Public Benefit Foundation

Polsky Urologic Cancer Institute

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acscentsci.2c00227

Reference140 articles.

1. The Cancer Immunotherapy Revolution

2. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

3. Cancer multidrug resistance

4. On the Origin of Cancer Metastasis

5. Delivering safer immunotherapies for cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Anchoring Strength Directly Correlates with Spherical Nucleic Acid–Based HPV E7 Cancer Vaccine Potency;Nano Letters;2024-06-14

2. Physicochemical Cues Steering Spiky Mn/MoOx Nanocarriers to Mimic Oncolytic Virus for Potentiating Cancer Immunotherapy;Advanced Functional Materials;2024-06-12

3. From Structure to Application: The Evolutionary Trajectory of Spherical Nucleic Acids;Small;2024-06-11

4. Polyvalent DNA-based bioorthogonal nano-agonist for robust chemo-immunotherapy;Materials Today;2024-06

5. Proteomimetic Polymers Trigger Potent Antigen-Specific T Cell Responses to Limit Tumor Growth;Journal of the American Chemical Society;2024-05-23